A lthough obesity in adulthood is a well-documented risk factor for both type 2 diabetes and coronary heart disease, it remains unclear whether a longer history of relative overweight, starting earlier in life, poses an additional risk. Furthermore, whereas the trajectory of weight and height from birth to adolescence is well documented, the progression of body-mass index (BMI) from adolescence into adulthood is less well described. Obese children probably have higher odds of becoming obese adults. 1 Moreover, although an elevated BMI in childhood or adolescence may not necessarily represent adiposity, 2-4 childhood obesity is associated with classic cardiometabolic risk factors, as is the case in adults. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Some studies [16] [17] [18] [19] [20] though not all 5, 7, 21, 22 -have shown that elevated BMI in childhood or adolescence is associated with an increased risk of disease or death later in life. What is lacking is knowledge of how childhood BMI interacts with the particular pathologic mechanisms of obesity-related diseases and whether it does so even within the BMI range that is now considered normal.
Given the current obesity pandemic, it is important to determine whether elevated BMI in childhood, adolescence, or adulthood, or an increase in BMI during the transition from adolescence to adulthood, contributes independently to the risk of disease. 23 Increases in BMI in childhood and adolescence may be closely associated with a higher incidence of coronary heart disease and type 2 diabetes mellitus in young adults. 24 In fact, the occurrence of these diseases in the third to fifth decades of life may be the result of distinct associations with risk factors that are overlooked when the diseases are studied later in life.
To address these points, we used data from the Metabolic, Lifestyle, and Nutrition Assessment in Young Adults (MELANY) 25 study of the Israel Defense Forces (IDF) Medical Corps and followed more than 37,000 apparently healthy young men whose BMI was measured at adolescence and into early adulthood, in order to identify incident cases of type 2 diabetes and angiography-proven coronary heart disease.
Me thods

Study Population
The MELANY study [25] [26] [27] [28] is an ongoing investigation conducted at the IDF Medical Corps Staff Periodic Examination Center (SPEC). All personnel remaining in the army beyond the period of mandatory military service are periodically examined (every 3 to 5 years) at the SPEC, beginning at approximately 25 years of age. At each examination, participants complete a questionnaire to provide demographic and medical information. Weight, height, and blood pressure are measured, and a complete physical examination is performed. Between SPEC visits, primary care for IDF personnel is provided at designated military clinics, and medical information is recorded in a central database, allowing ongoing, close, uniform follow-up, with repeated updates of measurements. For all the cohort participants, the SPEC database also includes data on weight and height measured at adolescence (17 years of age) obtained during an initial medical evaluation before induction into the army.
The study included 37,674 male career personnel whose BMI (calculated as the weight in kilograms divided by the square of the height in meters) at adolescence ranged between 15 and 36. Men with previously diagnosed diabetes (type 1 or 2) or coronary heart disease at adolescence were excluded, as were 135 men with newly diagnosed diabetes presenting with diabetic ketoacidosis and positive autoantibodies (diagnosis of type 1 diabetes). Among the 1173 men in whom incident diabetes developed during the study, 20 (1.7%) were suspected of having type 1 diabetes because of the need for rapid initiation of insulin treatment. Since no data on levels of autoantibodies were available for this subgroup, however, they were not excluded.
The IDF Institutional Review Board approved the study and waved the requirement for informed consent on the basis of the understanding that the anonymity of participants would be preserved.
Follow-up and Outcomes
Participants were followed prospectively from the time of their first visit to the SPEC (at ≥25 years of age). Their measured height and weight at 17 years of age (adolescence) were tracked retrospectively from the IDF central database. Two cases of diabetes were retrospectively defined as having developed between adolescence and the first SPEC visit. Follow-up ended at the time of diagnosis of diabetes or coronary heart disease, death, or retirement from military service or on December 31, 2007, whichever came first. Mean (±SD) total follow-up was 17.4±7.4 years (median, 16.9) (corresponding to conclusion of follow-up after at least 8 years for 99.99% of participants and after at least 12 years for 96.4%). There were 127 deaths during follow-up.
The diagnosis of 1173 incident cases of diabetes was based on two fasting plasma glucose levels of 126 mg per deciliter (7.0 mmol per liter) or higher, in accordance with criteria established by the American Diabetes Association Expert Committee. To accommodate changes in the diagnostic criteria for diabetes during follow-up, all fasting glucose values were reviewed to identify participants as having type 2 diabetes if their level of fasting plasma glucose was 126 to 140 mg per deciliter (7.0 to 7.8 mmol per liter). End-point determination was made at each sequential SPEC visit by measuring fasting glucose levels. Diagnoses of diabetes made between visits were established by IDF primary care physicians and confirmed by a committee of military physicians.
The outcome definition for coronary heart disease in MELANY 27 was angiography-proven stenosis of more than 50% in at least one coronary artery. Before 35 years of age, participants were referred for a diagnostic procedure on the basis of their own report of a specific problem; all participants 35 years of age or older underwent a treadmill exercise test (in accordance with the Bruce protocol) in the presence of a board-certified cardiologist. End points for the exercise test were ST-segment depression of more than 2 mm in two contiguous leads, measured 80 msec after the J point; symptoms of angina; exhaustion; or achievement of the target heart rate. All participants with an abnormal stress test were referred for coronary angiography. When the stress-test findings were borderline or when participants reported angina symptoms without diagnostic changes on electrocardiography, thallium-201 myocardial-perfusion imaging was performed, followed by coronary angiography for participants with an abnormal scan. Those presenting with symptoms of angina or myocardial infarction between SPEC visits were referred for coronary angiography after consultation with a boardcertified cardiologist.
Laboratory Methods
Glucose levels were determined at an on-site laboratory with the use of fresh blood samples collected in test tubes containing sodium fluoride to inhibit in vitro glycolysis. Biochemical analyses were performed at a laboratory authorized to perform tests according to the international quality standard ISO-9002. Lipids were measured directly, with the exception of low-density lipoproteins, which were calculated. Biochemical markers were measured with an automated analyzer (BM/Hitachi 917, Boehringer Mannheim).
Statistical Analysis
General linear models were used to compare ageadjusted means and proportions for the baseline characteristics of the population across the deciles of mean BMI at adolescence ( Table 1 ). The medians of the deciles were fit as continuous variables to estimate the trend of variables across deciles in a linear regression model. Cox proportionalhazards analysis, stratified according to the interval between SPEC visits, was used to estimate the hazard ratio and 95% confidence interval for the development of type 2 diabetes or coronary heart disease. Repeated assessments of smoking status, physical activity, and BMI in adulthood were time-dependent variables. We controlled for blood biomarkers only at baseline, since these variables might be part of the causal chain. In several steps, we gradually added to the age-adjusted model selected traditional risk factors considered to be potential confounders for the specific diseases, as detailed in Tables 2 and 3 . For both diabetes and coronary heart disease, the final model across deciles of adolescent BMI (model 4) was additionally adjusted for BMI in adulthood as a time-dependent, continuous variable. In addition, a linear model was used to assess adolescent BMI as a continuous variable. In a longitudinal growth chart, we depicted repeated BMI measurements from adolescence until data were censored in adulthood. BMI was stratified according to cutoff points established by the Centers for Disease Control and Prevention (CDC), with the use of the 10th, 25th, 50th, 75th, and 90th percentiles of the entire population. The curves corresponding to the 50th percentile for persons in whom coronary heart disease or diabetes developed were also calculated. To assess the interaction between quintiles of BMI at adolescence and in adulthood in relation to the risk of diabetes or coronary heart disease, we cross-classified the study population across 25 groups and excluded two extreme combinations (participants in quintile 1 in adolescence who were in quintile 5 in adulthood, and participants in quintile 5 in adolescence who were in quintile 1 in adulthood), each including less than 0.4% of the study population. All statistical analyses were performed with SPSS statistical software, version 16.0.
R e sult s
Characteristics of Study Participants
Characteristics of the cohort of 37,674 men across increasing deciles of BMI at adolescence are presented in Table 1 * Plus-minus values are means ±SD. Change in BMI (body-mass index, the weight in kilograms divided by the square of the height in meters) indicates the mean difference between BMI measured at 17 years of age (adolescence) and 30 years of age (adulthood). Family history of diabetes was defined as a first-degree relative of any age with diabetes, and family history of coronary heart disease (CHD) was defined as a first-degree male relative younger than 55 years of age with CHD or a first-degree female relative younger than 65 years of age with CHD. Intraassay and interassay coefficients of variation for glucose were both 2% at 6.6 mmol per liter; those for total cholesterol were 0.8% and 1.7%,respectively; those for triglycerides were 1.5% and 1.8%, respectively; and those for high-density lipoprotein (HDL) cholesterol were 2.9% and 3.6%, respectively. by 9.8% for each increment in 1 BMI unit (hazard ratio, 1.10; 95% CI, 1.08 to 1.12). In a multivariate model adjusted for age, presence or absence of a family history of coronary heart disease, blood pressure, physical activity, smoking status, and levels of LDL cholesterol, HDL cholesterol, and triglycerides, elevated adolescent BMI was a significant predictor of the incidence of angiography-proven coronary heart disease in young men across the entire BMI range (hazard ratio, 5.43; 95% CI, 2.77 to 10.62 between extreme deciles [model 3]) (Table 3 ). When adolescent BMI was modeled as a continuous variable in a multivariate model, the risk of coronary heart disease increased by 12.0% for each increment in 1 BMI unit (hazard ratio, 1.12; 95% CI, 1.067 to 1.18).
Trajectory of BMI
The trajectory of BMI between adolescence and young adulthood was studied longitudinally with the use of common CDC categories for growth charts (Fig. 1) . BMI progression lines increased in parallel with the transition from adolescence into young adulthood. Mean annual increase in BMI was 0.3 BMI units between the ages of 17 and 30 years (increasing by approximately 15 kg, or 4 BMI units), and 0.2 BMI units per year thereafter. The 50th percentile for the group of patients in whom either coronary heart disease or diabetes eventually developed deviated from the corresponding curve in the entire study population. (A complementary approach to describing BMI trajectory is shown in Fig. 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org.) For the entire study population, the correlation of adolescent BMI with adult BMI was r = 0.68.
We assessed whether diabetes and coronary heart disease are more closely associated with BMI in adolescence than in early adulthood. In a multivariate Cox model adjusted for age, presence or absence of a family history of diabetes, triglyceride levels, and fasting glucose levels, only BMI in adulthood was significantly associated with the risk of diabetes (β = 1.115, P = 0.003; P = 0.89 for interaction). In contrast, in a model adjusted for age, smoking status, presence or absence of a family history of coronary heart disease, and levels of HDL cholesterol, LDL cholesterol, and triglycerides, both the BMI in adolescence (β = 1.355, P = 0.004) and that in adulthood (β = 1.207, P = 0.03) were significantly and independently associated with the risk of coronary heart disease (P = 0.048 for interaction). These joint associations are depicted in Figures 2A and  2B . Furthermore, the addition of the repeated BMI measurements in adulthood to model 3 for diabetes (model 4, Table 2 ) completely attenuated the association between BMI in adolescence and the risk of diabetes, whereas for coronary heart disease (model 4, Table 3 ), adolescent BMI remained a risk factor that was independent of adult BMI.
To assess the importance of weight gain between adolescence and early adulthood in predicting subsequent incident diabetes or coronary heart disease, we calculated the change in BMI between the ages of 17 and 30 years and used it as a continuous variable. When added to the multivariate model (model 3 for each disease), adolescent BMI remained an independent predictor of both diabetes and coronary heart disease. The incremental change in BMI unit was an additional independent predictor of diabetes (hazard ratio, 1.083; 95% CI, 1.063 to 1.105), but not of coronary heart disease (hazard ratio, 1.006; 95% CI, 0.969 to 1.045). The change in BMI was lower among adolescents in the highest decile for BMI than among those in lower deciles (Table 1) , which may have led to an underestimation of the added deleterious effect of weight gain on the risk of coronary heart disease.
Discussion
This large-scale, long-term follow-up study suggests that elevated BMI in adolescence has distinctive relationships with type 2 diabetes and coronary heart disease in young adulthood. Diabetes is influenced mainly by recent BMI and weight gain, whereas for coronary heart disease both elevated BMI in adolescence and recent BMI are independent risk factors -that is, the natural history of coronary heart disease (in contrast with that of diabetes) is probably the consequence of gradually increasing atherosclerosis during adolescence and early adulthood that leads to clinically important disease in midlife. It is noteworthy that these conclusions were deduced with BMI values well within the range that is now defined as normal. Adolescent BMIs corresponding with the CDC growth charts at the percentiles of 49.3 (z score, −0.02) and 69.3 (z score, +0.51) were already associated with an increased risk of coronary heart disease and diabetes, respectively. These conclusions highlight the clinical importance of considering BMI history when assessing the risk of coronary heart disease versus the risk of diabetes in overweight or obese young adults. In terms of public health, this study supports concerns about the association between increasing cardiometabolic morbidity in early adulthood and the increase in BMI in adolescence, and the findings may suggest specific age-related considerations for the design of diabetes prevention programs that are distinct from those needed to prevent coronary heart disease. Finally, aided by the growth chart for young adults presented in Figure 1 , our study may help to redefine what constitutes a "normal" or "healthy" BMI in adolescence and to highlight the role of elevated BMI at different ages in the pathogenesis of different diseases. Our study has certain limitations. By the time they are 17 years old, not all boys will have completed puberty or reached their final height; thus, body composition at this age is not equivalent to that of adults, mainly because muscle mass is lower than that of adults. Indeed, increases in height between 17 and 30 years of age were greater on average in the lower deciles of BMI at adolescence; BMI increased by 4 units in the lower deciles and by 3 units in the 10th decile. Intriguingly, both early pubertal development and early adiposity rebound in childhood (the age at which BMI begins to rise after its physiologic nadir at 5 to 7 years of age) were implicated in the development of obesity. Thus, being placed in a lower decile for BMI during adolescence may be associated with having a lower risk of coronary heart disease or type 2 diabetes in early adulthood, reflecting a later onset of puberty or later increase in BMI.
A second consideration is waist circumference, a measure that would have been of value 7 in our study but that was not available to us. Nevertheless, the use of BMI, a ratiometric measure, may partly diminish the variation in height over weight. Third, generalization of the study's conclusions may be limited by the nature of the cohort -army personnel. However, the characteristics of our cohort are similar to those of other cohorts of young adults (as we discussed previously). 25 The exclusion of women precludes our ability to determine sex-based differences in the association between BMI and the risk of diabetes or heart disease; we recently addressed this concern as it relates to the incidence of hy- pertension. 26 The strengths of our follow-up study include well-documented outcomes based on strict diagnostic criteria, uniform and systematic follow-up assessments, a high rate of adherence during follow-up, standardized direct (rather than reported) measurements of weight and height, repeated measurements of many confounders, and the large size of the cohort. Some studies have not shown an association between childhood or adolescent BMI and coronary heart disease in adulthood. 22, 29, 30 However, our study suggests that adolescent BMI predicts angiography-proven coronary heart disease in young adulthood, a finding that is consistent with the results of the Norwegian Health Survey, 17 which showed that the risk of coronary heart disease in adulthood is increased by a factor of approximately three among adolescent boys whose BMI is in the 86th percentile or higher. The present analyses show that an elevated BMI in adolescence predicts coronary heart disease in early adulthood, even independently of the BMI at a point in time that is closer to the diagnosis, with a risk for the upper decile of adolescent BMI that is nearly seven times as high as that for the lowest decile. In fact, such a relationship already exists within the normal BMI range as defined by the CDC, which is lower than the cutoffs at the 85th percentile that are normally used in population surveys. Thus, obesity in adolescence is probably only the tip of an iceberg of BMI-related increases in the risk of coronary heart disease that is relevant to approximately 50% of adolescent boys. Remarkably, for type 2 diabetes, a significantly elevated hazard ratio was observed only in the 80th percentile of adolescent BMI and higher (>22.4), translating into a risk of disease that is nearly three times as high as that for those whose adolescent BMI is in the lowest decile. Moreover, adjustment for BMI in adulthood completely attenuated the effect, suggesting that BMI in adolescence has a more reversible or shorter term effect on the risk of diabetes as compared with its effect on the risk of coronary heart disease. Notably, however, those in the lowest decile for adolescent BMI tended to have a higher risk of future diabetes than those in the higher deciles, particularly when the analysis was adjusted for BMI in adulthood.
Our results might be explained by the fact that diabetes represents a more functional pathomechanism than coronary heart disease, which relies on anatomical changes (atherosclerosis). Such an explanation is consistent with the fact that even clinically established diabetes is readily reversible in response to changes in lifestyle or surgical interventions, whereas atherosclerosis, for example, is responsive to dietary interven- The joint association of body-mass index (BMI) at 17 years of age (adolescence) and 30 years of age (adulthood) is shown for the incidence of diabetes (Panel A) and the incidence of angiography-proven coronary heart disease (CHD) (Panel B), as calculated with the use of multivariate Cox proportional-hazards models. The gray columns denote significantly elevated hazard ratios as compared with those in the lowest BMI quintile in both adolescence and adulthood (reference group). When BMI was analyzed as a continuous variable with the use of a Cox regression model adjusted for age, triglyceride level, presence or absence of a family history of diabetes, and fasting glucose level, only BMI in adulthood was significantly associated with the risk of diabetes (β = 1.115, P = 0.003; P = 0.89 for interaction with BMI in adolescence). In contrast, in a regression model adjusted for age, triglyceride level, smoking status, presence or absence of a family history of CHD, and levels of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol, BMI in both adolescence and adulthood was significantly and independently associated with the risk of CHD (BMI in adolescence, β = 1.355, P=0.004; BMI in adulthood, β = 1.207, P = 0.03; P < 0.05 for interaction).
